IP Library Granted Patent US 9,944,584
Granted Patent B2
US 9,944,584 · App. 15/123,520 · Granted Apr 17, 2018

Method for removing mineral acid from levulinic acid

Inventors: Brian D. Mullen (Delano, MN); Vivek Badarinarayana (St. Louis Park, MN)
Assignee: GFBIOCHEMICALS LIMITED
C07C51/48B01D11/0426B01D11/0492
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,944,584
App. No.
15/123,520
Granted
Apr 17, 2018
Kind
B2
Abstract

The invention describes processes to selectively remove or reduce the mineral acid content substantially from compositions comprising a solvent and levulinic acid, wherein the levulinic acid was derived from the reaction between various biomass materials and a mineral acid or an organic acid catalyst.

Claims (15)

1. A method to prepare a levulinic acid composition substantially without an acid catalyst present comprising the steps:

preparing an aqueous levulinic acid composition comprising levulinic acid, an acid catalyst and water;

combining the aqueous levulinic acid solution with an immiscible organic solvent to form a mixture;

partitioning the mixture into an aqueous phase and an organic phase; and

washing the organic phase with an aqueous treatment solution comprising one or more monosaccharides, one or more disaccharides, or a mixture thereof to reduce the acid catalyst content in the organic phase.

2. The method of claim 1 , further comprising the step of separating the aqueous phase from the organic phase.

3. The method of claim 1 , wherein the reduction of acid catalyst in the levulinic acid composition after treatment with the aqueous treatment solution is at least two fold.

4. The method of claim 1 , wherein the reduction of acid catalyst in the levulinic acid composition after treatment with the aqueous treatment solution is at least ten fold or greater.

5. The method of claim 1 , wherein the concentration of acid catalyst that remains in the organic phase is less than 100 ppm.

6. The method of claim 1 , wherein the organic solvent is methyl-isobutyl ketone (MIBK), methyl isoamyl ketone (MIAK), cyclohexanone, o, m, and para-cresol, substituted phenols, for example, 2-sec butyl phenol, C4-C18 alcohols, such as n-pentanol, isoamyl alcohol, n-heptanol, 2-ethyl hexanol, n-octanol, 1-nonanol, cyclohexanol, methylene chloride, 1,2-dibutoxy-ethylene glycol, acetophenone, isophorone, o-methoxy-phenol, methyl-tetrahydrofuran, tri-alkylphosphine oxides (C4-C18) and ortho-dichlorobenzene and mixtures thereof or the like, more specifically, methyl isoamyl ketone (MIAK), o, m, and para-cresol, phenol, isoamyl alcohol, n-hexanol, n-heptanol, 2-ethyl hexanol, o-methoxy-phenol, 2-4 dimethyl phenol, methyl isobutyl carbinol, and mixtures thereof or the like, and even more specifically, phenol, all isomers of fluoro, chloro, bromo, and iodo phenols, bis-halogenated phenols, mixtures of halogenated phenols, xylenols, gamma-valerolactone, isoamyl alcohol, neopentyl alcohol, methyl isobutyl carbinol, and mixtures thereof.

7. The method of claim 1 , wherein the monosaccharide is glucose, fructose or mixtures thereof and/or the disaccharide is maltose, sucrose or mixtures thereof.

8. The method of claim 1 , wherein the concentration of monosaccharide and/or disaccharide present in the aqueous solution is from about 5% to about 80% by weight based on the total weight of the mixture.

9. The method of any of claims 1 through 8 , wherein the concentration of acid catalyst present is from about 0.01% to about 5% by weight based on the total weight of the mixture.

10. The method of claim 1 , wherein the concentration of levulinic acid present is from about 1% to about 30% by weight based on the total weight of the mixture.

11. The method of claim 1 , wherein the acid catalyst is sulfuric acid or hydrochloric acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2018
From: MULLEN, BRIAN D.; BADARINARAYANA, VIVEK
To: GFBIOCHEMICALS LIMITED
Reel/Frame 046806/0655 →
Continuity (2)
Provisional Application 61947185 · Mar 3, 2014
Related Publication 20160368850A1 · Dec 22, 2016